Total Payments
$4,670
2024 Payments
$660.62
Companies
47
Transactions
310
Medicare Patients
4,247
Medicare Billing
$341,456
Payment Breakdown by Category
Food & Beverage$4,670 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,670 | 310 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $965.63 | 81 | $0 (2024) |
| Lilly USA, LLC | $403.64 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $323.27 | 22 | $0 (2023) |
| PFIZER INC. | $319.97 | 26 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $292.28 | 13 | $0 (2024) |
| Amgen Inc. | $288.28 | 17 | $0 (2022) |
| ABBVIE INC. | $263.33 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $175.31 | 17 | $0 (2023) |
| Stryker Corporation | $170.13 | 1 | $0 (2024) |
| SANOFI PASTEUR INC. | $148.85 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $660.62 | 32 | Novo Nordisk Inc ($190.95) |
| 2023 | $887.32 | 51 | ABBVIE INC. ($135.83) |
| 2022 | $506.28 | 27 | Novo Nordisk Inc ($93.79) |
| 2021 | $77.94 | 6 | CooperSurgical, Inc. ($26.06) |
| 2020 | $471.42 | 38 | Novo Nordisk Inc ($174.39) |
| 2019 | $761.56 | 62 | Novo Nordisk Inc ($191.26) |
| 2018 | $562.79 | 37 | Novo Nordisk Inc ($176.89) |
| 2017 | $742.18 | 57 | Merck Sharp & Dohme Corporation ($114.32) |
All Payment Transactions
310 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Biological | ||||||
| 11/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.24 | General |
| 10/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | Stryker Corporation | INBONE (Device), INVISION, PROPHECY | Food and Beverage | In-kind items and services | $170.13 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Obesity | ||||||
| 09/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: ETONOGESTREL | ||||||
| 05/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,020 | 1,450 | $243,299 | $94,774 |
| 2022 | 17 | 1,155 | 1,480 | $244,425 | $89,495 |
| 2021 | 16 | 973 | 1,264 | $214,354 | $75,845 |
| 2020 | 15 | 1,099 | 1,440 | $254,722 | $81,341 |
Total Patients
4,247
Total Services
5,634
Medicare Billing
$341,456
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 393 | $101,394 | $30,277 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 169 | 169 | $47,320 | $20,773 | 43.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 33 | 293 | $29,007 | $12,785 | 44.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 90 | 90 | $5,400 | $5,292 | 98.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 26 | $14,456 | $5,086 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 85 | $14,790 | $4,066 | 27.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,550 | $3,931 | 86.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 19 | $7,467 | $2,784 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 96 | 96 | $4,320 | $2,748 | 63.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $5,782 | $2,201 | 38.1% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 15 | 15 | $1,773 | $1,738 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 92 | 95 | $2,185 | $798.00 | 36.5% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 15 | 15 | $900.00 | $572.55 | 63.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 15 | 15 | $900.00 | $572.55 | 63.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 59 | $1,475 | $561.68 | 38.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $630.00 | $400.82 | 63.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 21 | 21 | $525.00 | $128.31 | 24.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 17 | $425.00 | $57.97 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 261 | 398 | $102,684 | $28,683 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 164 | 164 | $45,920 | $20,507 | 44.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 28 | 168 | $16,632 | $7,292 | 43.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 45 | 45 | $18,585 | $7,227 | 38.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 26 | 32 | $17,792 | $6,751 | 37.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 91 | 94 | $5,640 | $5,536 | 98.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 106 | $18,444 | $5,050 | 27.4% |
About Dr. David Porter, MD
Dr. David Porter, MD is a Family Medicine healthcare provider based in Columbus, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467410100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Porter, MD has received a total of $4,670 in payments from pharmaceutical and medical device companies, with $660.62 received in 2024. These payments were reported across 310 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($4,670).
As a Medicare-enrolled provider, Porter has provided services to 4,247 Medicare beneficiaries, totaling 5,634 services with total Medicare billing of $341,456. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Columbus, IN
- Active Since 05/03/2006
- Last Updated 09/09/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1467410100
Products in Payments
- Ozempic (Drug) $382.58
- TRULICITY (Drug) $209.73
- Rybelsus (Drug) $190.18
- INBONE (Device) $170.13
- Prolia (Biological) $161.14
- FARXIGA (Drug) $159.92
- CHANTIX (Drug) $140.56
- Tresiba (Drug) $125.51
- SHINGRIX (Biological) $123.59
- QULIPTA (Drug) $115.55
- Victoza (Drug) $105.16
- Aimovig (Biological) $104.72
- EMGALITY (Drug) $99.48
- SYMBICORT (Drug) $88.23
- VRAYLAR (Drug) $86.23
- LEQVIO (Drug) $77.84
- JANUVIA (Drug) $72.65
- REXULTI (Drug) $70.72
- Saxenda (Drug) $70.36
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $69.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Columbus
Brian Beesley, Do, DO
Family Medicine — Payments: $1.5M
Family Medicine $1.5M
Dr. Jeffrey Kingsley, D.o, D.O
Family Medicine — Payments: $407,144
Family Medicine $407,144
Dr. Joseph Surber, Do, DO
Family Medicine — Payments: $147,174
Family Medicine $147,174
Bantwal Baliga, Md,Dgo, MD,DGO
Family Medicine — Payments: $124,562
Family Medicine $124,562
Bryan Feldman, D.o, D.O
Family Medicine — Payments: $48,287
Family Medicine $48,287
Elizabeth Martin, M.d, M.D
Family Medicine — Payments: $27,168
Family Medicine $27,168